New Survey for the NET Community

You can help advance research in the neuroendocrine tumor community by participating in an international survey being conducted by a pharmaceutical company in the United States, United Kingdom, Ireland, and Canada. The goal of the study is to better understand the experience of somatostatin analog injections, particularly pain at the injection site and its impact on daily life. READ MORE and TAKE THE SURVEY

Thank you so much to all who completed the survey — your responses make a difference for everyone in the NET community!  Due to an overwhelming response, the survey is now closed (as of September 1).

Print Friendly, PDF & Email